Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The SARS-CoV 2 pandemic started in China in December 2019, then reached France on January 24, 2020.
On March 14, France moved into phase 3 of the epidemic threshold with the implementation of containment measures on March 17 Measures were put in place by N.Belloubet (French Minister of Justice) from March 17, including suspension of visiting rooms and activities in detention.
Containment provides boredom and isolation with many potential consequences: sleep disturbance, anxiety, PTSD, depression, suicide, addictive behavior and violence.
However,prisoners have a higher prevalence of substance use disorders than the general population.
What will have been the impact of the confinement on the consumption of psychoactive substances by prisoners at the Villeneuve Les Maguelone prison.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| percentage changes in the consumption of psychoactive substances | percentage changes in the consumption of psychoactive substances | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of the level of stress | Assessment of the level of stress by self-administered questionnaire before / during confinement | 1 day |
| Assessment of depression | Assessment of depression by self-administered questionnaire before / during confinement |
Not provided
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
People incarcerated in Villeneuve-Lès-Maguelon prison
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Aurélie Mieuset, PhD | University Hospitals of Montpellier | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UH Montpellier | Montpellier | 34295 | France |
NC
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 day |
| Craving modification evaluation | Craving modification evaluation | 1 day |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |